FDA Inspection
Grifols Canada Plasma Inc.Grifols Canada Plasma Inc. – FDA Inspection, Sep 18, 2014
Record Details
This FDA Inspection record concerns Grifols Canada Plasma Inc., with an inspection on September 18, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Grifols Canada Plasma Inc.
- Inspection Date
- September 18, 2014
- Product Type
- Biologics
View Company Profile
ID · 3ccd32ca-3eb0-438a-8dad-d6b25a61a0c7
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 897645
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Grifols Canada Plasma Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| July 16, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 8, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 16, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 18, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 16, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Grifols Canada Plasma Inc.
- FDA Inspection 1244904 - 2024-07-16
- FDA Inspection 1171951 - 2022-06-08
- FDA Inspection 1054297 - 2018-05-16
- FDA Inspection 986975 - 2016-05-18
- FDA Inspection 800544 - 2012-08-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.